Literature DB >> 17036173

Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats.

S-D Jiang1, L-S Jiang, L-Y Dai.   

Abstract

INTRODUCTION: Spinal cord injury (SCI) causes a significant amount of bone loss in the sublesional area in animals and humans, and this type of bone loss is different from other forms of osteoporosis such as disuse osteoporosis and postmenopausal osteoporosis. However, no data is available on the cellular and molecular changes of osteoblastogenesis and osteoclastogenesis during SCI-induced bone loss.
METHODS: SCI and SHAM rats were used in this study to investigate osteoblastogenesis and osteoclastogenesis in bone-marrow culture. We also measured bone mass and bone histomorphometry, as well as the expression of alkaline phosphatase (ALP), core binding factor alpha1 (Cbfa-1), osterix, receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG) in osteoblast-like cells in bone-marrow culture obtained from SCI and SHAM rats.
RESULTS: Bone mineral density (BMD) measurement showed serious bone loss in the tibial ephiphyses and metaphyses of SCI rats compared with SHAM rats. In addition, bone histomorphometry analysis of the tibial metaphyses of SCI rats demonstrated that bone microarchitecture in SCI rats deteriorated further than in SHAM rats, and increased eroded surfaces and bone formation rates were observed in SCI rats. The number of osteoclasts that developed from bone marrow of SCI rats at equal density was significantly increased compared with SHAM rats, and the area of the resorption pits formed in the bone marrow culture from SCI rats was significantly greater than SHAM rats, whereas the number of CFU-F and CFU-OB was similar in both groups. RANKL mRNA and protein levels in osteoblast-like cells in culture obtained from SCI rats were significantly higher than those from the SHAM rats, whereas OPG levels decreased slightly. The ratios of RANKL to OPG expression in SCI rats were significantly higher than those in SHAM rats. However, osteogenic gene profiling of Cbfa-1, ALP and osterix in SCI rats remained similar with SHAM rats.
CONCLUSION: These changes favor increased osteoclast activity over osteoblast activity, and may explain, in part, the imbalance in bone formation and resorption following SCI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036173     DOI: 10.1007/s00198-006-0229-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  77 in total

1.  The effects of stimulators of intracellular cyclic AMP on rat and chick osteoclasts in vitro: validation of a simplified light microscope assay of bone resorption.

Authors:  R J Murrills; D W Dempster
Journal:  Bone       Date:  1990       Impact factor: 4.398

2.  Longitudinal study of calcium and bone metabolism in paraplegic patients.

Authors:  P Bergmann; A Heilporn; A Schoutens; J Paternot; A Tricot
Journal:  Paraplegia       Date:  1977-08

3.  Longitudinal study of bone turnover after acute spinal cord injury.

Authors:  D Roberts; W Lee; R C Cuneo; J Wittmann; G Ward; R Flatman; B McWhinney; P E Hickman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK.

Authors:  H Mukohyama; M Ransjö; H Taniguchi; T Ohyama; U H Lerner
Journal:  Biochem Biophys Res Commun       Date:  2000-04-29       Impact factor: 3.575

6.  Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Authors:  M M Bliziotes; A J Eshleman; X W Zhang; K M Wiren
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

7.  Increased osteoclast-like cells formation in long-term bone marrow cultures from patients with a spinal cord injury.

Authors:  A Demulder; M Guns; A Ismail; E Wilmet; P Fondu; P Bergmann
Journal:  Calcif Tissue Int       Date:  1998-11       Impact factor: 4.333

8.  Intra-medullary pressure and intra-osseous phlebography in paraplegia.

Authors:  A Chantraine; C van Ouwenaller; H J Hachen; P Schinas
Journal:  Paraplegia       Date:  1979-11

9.  Use of bone biochemical markers with dual-energy x-ray absorptiometry for early determination of bone loss in persons with spinal cord injury.

Authors:  Laurent Maïmoun; Isabelle Couret; Jean-Paul Micallef; Edouard Peruchon; Denis Mariano-Goulart; Michel Rossi; Jean-Louis Leroux; Freddy Ohanna
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

10.  Substance P- and CGRP-immunoreactive nerves in bone.

Authors:  A Bjurholm; A Kreicbergs; E Brodin; M Schultzberg
Journal:  Peptides       Date:  1988 Jan-Feb       Impact factor: 3.750

View more
  17 in total

1.  Difference in intraosseous blood vessel volume and number in osteoporotic model mice induced by spinal cord injury and sciatic nerve resection.

Authors:  Wen-Ge Ding; Wei-hong Yan; Zhao-Xiang Wei; Jin-Bo Liu
Journal:  J Bone Miner Metab       Date:  2011-11-08       Impact factor: 2.626

2.  Bone loss and impaired fracture healing in spinal cord injured mice.

Authors:  W-G Ding; S-D Jiang; Y-H Zhang; L-S Jiang; L-Y Dai
Journal:  Osteoporos Int       Date:  2010-05-06       Impact factor: 4.507

3.  Isolated osteoblasts from spinal cord-injured rats respond less to mechanical loading as compared with those from hindlimb-immobilized rats.

Authors:  Sheng-Dan Jiang; Yue-Hua Yang; Jiang-Wei Chen; Lei-Sheng Jiang
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

4.  Surgical management of lower limb fractures in patients with spinal cord injury less associated with complications than non-operative management: A retrospective series of cases.

Authors:  Alban Fouasson-Chailloux; Raphael Gross; Marc Dauty; Guillaume Gadbled; Sophie Touchais; Marc Le Fort; Brigitte Perrouin-Verbe
Journal:  J Spinal Cord Med       Date:  2017-05-10       Impact factor: 1.985

5.  Bone loss following spinal cord injury in a rat model.

Authors:  Michael J Voor; Edward H Brown; Qian Xu; Seid W Waddell; Robert L Burden; Darlene A Burke; David S K Magnuson
Journal:  J Neurotrauma       Date:  2012-02-22       Impact factor: 5.269

6.  Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.

Authors:  L Gifre; J Vidal; J L Carrasco; A Muxi; E Portell; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2015-09-30       Impact factor: 4.507

7.  Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.

Authors:  L Gifre; S Ruiz-Gaspà; J L Carrasco; E Portell; J Vidal; A Muxi; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2017-06-04       Impact factor: 4.507

8.  Spinal cord injury causes rapid osteoclastic resorption and growth plate abnormalities in growing rats (SCI-induced bone loss in growing rats).

Authors:  L Morse; Y D Teng; L Pham; K Newton; D Yu; W-L Liao; T Kohler; R Müller; D Graves; P Stashenko; R Battaglino
Journal:  Osteoporos Int       Date:  2007-11-07       Impact factor: 4.507

9.  Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats.

Authors:  Hua-Dong Wang; Ya-Min Shi; Li Li; Ji-Dong Guo; Yu-Peng Zhang; Shu-Xun Hou
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

10.  Anatomic changes in the macroscopic morphology and microarchitecture of denervated long bone tissue after spinal cord injury in rats.

Authors:  Ariane Zamarioli; Daniel A Maranho; Mariana M Butezloff; Patrícia A Moura; José Batista Volpon; Antônio C Shimano
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.